DOCSLIB.ORG

The History of the First Kidney Transplantation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The History of the First Kidney Transplantation 165+3 14 mm "Service to society is the rent we pay for living on this planet" The History of the Joseph E. Murray, 1990 Nobel-laureate who performed the first long-term functioning kidney transplantation in the world First Kidney "The pioneers sacrificed their scientific life to convince the medical society that this will become sooner or later a successful procedure… – …it is a feeling – now I am Transplantation going to overdo - like taking part in creation...” András Németh, who performed the first – a European Overview Hungarian renal transplantation in 1962 E d i t e d b y : "Professor Langer contributes an outstanding “service” to the field by a detailed Robert Langer recording of the history of kidney transplantation as developed throughout Europe. The authoritative information is assembled country by country by a generation of transplant professionals who knew the work of their pioneer predecessors. The accounting as compiled by Professor Langer becomes an essential and exceptional reference document that conveys the “service to society” that kidney transplantation has provided for all mankind and that Dr. Murray urged be done.” Francis L. Delmonico, M.D. Professor of Surgery, Harvard Medical School, Massachusetts General Hospital Past President The Transplantation Society and the Organ Procurement Transplant Network (UNOS) Chair, WHO Task Force Organ and Tissue Donation and Transplantation The History of the First Kidney Transplantation – a European Overview European a – Transplantation Kidney First the of History The ISBN 978-963-331-476-0 Robert Langer 9 789633 314760 The History of the First Kidney Transplantation – a European Overview Edited by: Robert Langer SemmelweisPublishers www.semmelweiskiado.hu Budapest, 2019 © Semmelweis Press and Multimedia Studio Budapest, 2019 eISBN 978-963-331-473-9 All rights reserved. No part of this work covered by the copyrights hereon may be reproduced or copied in any form or by any means – graphic, electronic or mechanical, including photocopying, recording, taping on information storage and retrieval systems – without written permission of the author and the publisher. Editor in Chief: László Táncos, director Layout: János Békésy Cover: László Táncos SKD: 622 Contents Lectori salutem ....................................................................... 7 The European Prelude Ukraine ...................................................................................... 13 The American Prelude – Message from the English Editor United States of America .................................................... 18 France ........................................................................................ 23 Norway ...................................................................................... 27 United Kingdom .................................................................... 30 Belgium ..................................................................................... 37 Spain .......................................................................................... 42 Czech Republic ....................................................................... 46 Hungary .................................................................................... 51 Germany ................................................................................... 57 Ireland ........................................................................................ 60 Denmark ................................................................................... 64 Finland ....................................................................................... 67 Sweden ...................................................................................... 69 Switzerland .............................................................................. 72 Russia ......................................................................................... 76 Austria ........................................................................................ 81 Poland ........................................................................................ 86 Netherlands ............................................................................. 91 Italy ............................................................................................. 97 Bulgaria ..................................................................................... 101 Estonia ....................................................................................... 106 Greece ....................................................................................... 110 Portugal .................................................................................... 114 Lithuania ................................................................................... 117 Slovenia ..................................................................................... 121 Belarus ....................................................................................... 125 Croatia ....................................................................................... 8 12 Azerbaijan ................................................................................ 134 Serbia ......................................................................................... 136 Latvia ......................................................................................... 143 Slovakia ..................................................................................... 140 Bosnia and Herzegovina ..................................................... 148 Latvia ......................................................................................... 143 Turkey ........................................................................................ 150 Bosnia and Herzegovina ..................................................... 148 Georgia ...................................................................................... 158 Turkey ........................................................................................ 150 Macedonia ............................................................................... 160 Georgia ...................................................................................... 158 Armenia ..................................................................................... 165 Macedonia ............................................................................... 160 Luxembourg ............................................................................ 170 Armenia ..................................................................................... 165 Romania .................................................................................... 173 Luxembourg ............................................................................ 170 Malta .......................................................................................... 175 Romania .................................................................................... 3 17 Moldova .................................................................................... 179 Malta .......................................................................................... 175 Cyprus ........................................................................................ 183 Moldova .................................................................................... 179 Iceland ....................................................................................... 187 Cyprus ........................................................................................ 183 Albania ...................................................................................... 191 Iceland ....................................................................................... 187 Kosovo ....................................................................................... 195 Albania ...................................................................................... 191 Montenegro ............................................................................ 200 Kosovo ....................................................................................... 195 Montenegro ............................................................................ 200 Lectori salutem When I was elected to be the Chair of EKITA, the European Kidney Trans- plantation Association, I raised the question, who do we represent? According to the official definitions, Europe is spread from Iceland to the Ural mountain; more than 40 members belong to the Council of Europe, the states called European. All of these countries have initiated renal transplantations. An idea was born to demonstrate our togetherness: each and every country has the opportunity to present its “very first” such operation. Finally, beside the pioneer Ukrainian and American contributions 44 European stories are recorded in this book. We have to mention that some citizens of European mini states where transplant programs are not present (because of the small number of poten- tial patients) have the possibility to be transplanted in neighbouring countries: Andorra (Spain and France), San Marino and Vatican (Italy), Monaco (France) and Liechtenstein (Switzerland and Austria). But the remaining European countries are traditionally nationally organized, with organ exchanges rarely happening, except for Eurotransplant 8 Western and Middle European countries, Scandi- atransplant (Scandinavian countries) and Balttransplant (Baltic states) where regular organ exchanges
Load more

Recommended publications
  • Immunosuppressive Effects in Infection
    I Volume 63 January 1970 I1I J- 6 JAN'7O Section of Clinical ~~~~~~~~~ Immunology & Allergy President Professor Sir Michael Woodruff FRCS FRS Meeting April 14 1969 Immunosuppressive Effects in Infection Dr M H Salaman Measles: In 1908 von Pirquet noticed that the (Department ofPathology, Royal College tuberculin reaction in tuberculous children be- ofSurgeons oJ England, came negative during an attack of measles, and London) that afterwards tuberculosis often advanced rapidly. Later work has confirmed his observa- Immunodepression by tions on tuberculin sensitivity by more sensitive Mammalian Viruses and Plasmodia methods (Mellman & Wetton 1963, Brody & McAlister 1964, Starr & Berkovitch 1964), and it Depression of immune responses by viruses is has been shown (Smithwick & Berkovitch 1966) receiving increasing though much belated atten- that measles virus, added to lymphocytes of tion. Early reports (von Pirquet 1908, Bloomfield tuberculin-positive patients, prevents the mito- & Mateer 1919) were forgotten and the subject genic response to tuberculin PPD, but not the neglected till 1960 when Old and his colleagues response to phytohmmagglutinin (PHA). noticed that the hmemolysin response to sheep erythrocytes (SE) was depressed in mice infected Rubella: In infants with congenital rubella there with Friend's leukeemogenic virus (FV), and is no gross defect of antibody formation, but their Gledhill (1961) found that FV and Moloney virus lymphocytes do not respond to PHA (Alford both enhanced the pathogenicity of mouse 1965, Bellanti et al. 1965, Soothill et al. 1966). hepatitis virus. Since then reports of immuno- Normal lymphocytes treated with rubella virus in depression by a wide variety of viruses, both vitro lose their PHA-responsiveness.
    [Show full text]
  • Newsletteralumni News of the Newyork-Presbyterian Hospital/Columbia University Department of Surgery Volume 13, Number 1 Summer 2010
    NEWSLETTERAlumni News of the NewYork-Presbyterian Hospital/Columbia University Department of Surgery Volume 13, Number 1 Summer 2010 CUMC 2007-2009 Transplant Activity Profile* Activity Kidney Liver Heart Lung Pancreas Baseline list at year start 694 274 174 136 24 Deceased donor transplant 123 124 93 57 11 Living donor transplant 138 17 — 0 — Transplant rate from list 33% 50% 51% 57% 35% Mortality rate while on list 9% 9% 9% 15% 0% New listings 411 217 144 68 23 Wait list at year finish 735 305 204 53 36 2007-June 2008 Percent 1-Year Survival No % No % No % No % No % Adult grafts 610 91 279 86 169 84 123 89 6 100 Adult patients 517 96 262 88 159 84 116 91 5 100 Pediatric grafts 13 100 38 86 51 91 3 100 0 — Pediatric patients 11 100 34 97 47 90 2 100 0 — Summary Data Total 2009 living donor transplants 155 (89% Kidney) Total 2009 deceased donor transplants 408 (30% Kidney, 30% Liver) 2007-June 2008 adult 1-year patient survival range 84% Heart to 100% Pancreas 2007-June 2008 pediatric 1-year patient survival range 90% Heart to 100% Kidney or lung *Health Resource and Service Administration’s Scientific Registry of Transplant Recipients (SRTR) Ed Note. The figure shows the US waiting list for whole organs which will only be partially fulfilled by some 8,000 deceased donors, along with 6,600 living donors, who will provide 28,000 to 29,000 organs in 2010. The Medical Center’s role in this process is summarized in the table, and the articles that follow my note expand on this incredible short fall and its potential solutions.
    [Show full text]
  • Cooperating Saves Lives Start Contents
    Annual Report 2019 Cooperating saves lives start contents Contents Foreword 1. The Eurotransplant community 2. Eurotransplant: donation, allocation, transplantation and waiting lists This document is optimized for Acrobat Reader for best viewing 3. Report of the Board and the central office experience. 4. Histocompatibility Testing Download Acrobat Reader 5. Reporting of non-resident transplants in Eurotransplant 6. Transplant programs and their delegates in 2019 A high resolution version of this document is also available. 7. Scientific output in 2019 Download high resolution pdf 8. Eurotransplant personnel related statistics 9. Abbreviated financial statements All rights reserved. No part of this publication may be reproduced, stored in a retrieval system List of abbreviations or transmitted, in any form or by any means, electronic, mechanical, photocopying or elsewise, without prior permission of Eurotransplant. For permissions, please contact: [email protected] start contents Foreword Dear reader, We are proud to offer you the 2019, digital edition of the International organ exchange Eurotransplant Annual Report. In this environmentally In 2019, 6981 organs from 2042 deceased donors were friendly, digital report you can easily browse via the used for transplantation for patients on the waiting top menu. Weblinks are added to facilitate in finding list of Eurotransplant. This decrease of the number of more specific information on relevant websites. The reported donors is 5,5% compared to 2018 (2159). report provides an overview of the key statistics on 21.5% of organs were exchanged cross-border between organ donation, allocation and transplantation in all the Eurotransplant member states. Thanks to this Eurotransplant countries. international exchange, a suitable donor organ could be You can also read in the report activities within found for many patients in the different Eurotransplant Eurotransplant that took place, decisions that were member states.
    [Show full text]
  • Analysis of the Trend Over Time of High-Urgency Liver Transplantation Requests in Italy in the 4-Year Period 2014-2017
    Analysis of the Trend Over Time of High-Urgency Liver Transplantation Requests in Italy in the 4-Year Period 2014-2017 S. Trapani*, F. Puoti, V. Morabito, D. Peritore, P. Fiaschetti, A. Oliveti, M. Caprio, L. Masiero, L. Rizzato, L. Lombardini, A. Nanni Costa, and M. Cardillo Italian National Transplant Center, Italian Institute of Health, Rome, Italy ABSTRACT Background. The national protocol for the handling of high-urgency (HU) liver organ procurement for transplant is administered by the Italian National Transplant Center. In recent years, we have witnessed a change in requests to access the program. We have therefore evaluated their temporal trend, the need to change the access criteria, the percentage of transplants performed, the time of request satisfaction, and the follow-up. Methods. We analyzed all the liver requests for the HU program received during the 4-year period of 2014 to 2017 for adult recipients (18 years of age): all the variables linked to the recipient or to the donor and the organ transplants are registered in the Informative Transplant System as established by the law 91/99. In addition, intention to treat (ITT) survival rates were compared among 4 different groups: (1) patients on standard waiting lists vs (2) patients on urgency waiting lists, and (3) patients with a history of transplant in urgency vs (4) patients with a history of transplant not in urgency. Results. Out of the 370 requests included in the study, 291 (78.7%) were satisfied with liver transplantation. Seventy-nine requests (21.3%) have not been processed, but if we consider only the real failures, this percentage falls to 13.1% and the percentage of satisfied requests rises to 86.9%.
    [Show full text]
  • Spain, France and Italy Are to Exchange Organs for Donation Chains
    Translation of an article published in the Spanish newspaper ABC on 10 October 2012 O.J.D.: 201504 Date: 10/10/2012 E.G.M.: 641000 Section: SOCIETY Pages: 38, 39 ----------------------------------------------------------------------------------------------------------------- This is what happened in Spain’s first ‘crossover’ transplant [For diagram see original article] Altruistic donor The chain started with the kidney donation from a ‘good Samaritan’ going to a recipient in a couple. The wife of the first recipient donated her kidney to a sick person in a second couple. The wife of the second recipient donated her kidney to a third patient on the waiting list. On the waiting list The final recipient, selected using medical criteria, was on the waiting list to receive a kidney from a deceased donor for three years. Spain, France and Italy are to exchange organs for donation chains ► The creation of this type of ‘common area’ in southern Europe will increase the chances of finding a donor match CRISTINA GARRIDO BRUSSELS | Stronger together. Although there are many things on which we find it difficult to agree, this time the strategy was clear. Spain, France and Italy have signed the Southern Europe Transplant Alliance to promote their successful donation and transplant system – which is public, coordinated and directly answerable to the Ministries of Health, as compared to the private models of central and northern Europe – to the international bodies. ‘We (Spain, France and Italy) decided that we had to do something together because we have similar philosophies, ethical criteria and structures and we could not each go our own way given how things are in the northern countries’, explained Dr Rafael Matesanz, Director of the Spanish National Transplant Organisation, at the seminar on donations and transplants organised by the European Commission in Brussels yesterday.
    [Show full text]
  • 160528 Dr. Edgar Franke
    Prof. Dr. J. Floege • Rheinisch-Westfälische Technische Hochschule Aachen Universitätsklinikum • Medizinische Klinik II • Pauwelsstr. 30 • 52074 Aachen Geschäftsstelle Seumestr. 8 10245 Berlin Dr. Edgar Franke Ausschuss für Gesundheit Telefon: 030 52137269 Deutscher Bundestag Telefax: 030 52137270 Platz der Republik 1 E-Mail: [email protected] 11011 Berlin www.dgfn.eu Berlin, 29.5.2016 Vorstand: Prof. Dr. J. Floege (Präsident) Rheinisch-Westfälische Sehr geehrter Herr Dr. Franke, Technische Hochschule Aachen Universitätsklinikum Medizinische Klinik II, die Dt. Gesellschaft für Nephrologie bedankt sich für die Gelegenheit Nephrologie und Klinische einer Stellungnahme zum geplanten Transplantationsregister. Immunologie Pauwelsstr. 30 Wir begrüßen die Initiative eines bundesweiten Transplantationsregisters 52074 Aachen ausdrücklich, möchten aber unter Bezugnahme auf das mit Frau Prof. Dr. Elke Telefon: 0241 8089530 Schäffner am 15.4.16 geführte Obleutegespräch an dieser Stelle erneut auf Telefax: 0241 8082446 E-Mail: [email protected] einen Umstand hinweisen, der unserer Ansicht nach in dem bisherigen Gesetzesentwurf zu kurz greift, die Verknüpfung eines Prof. Dr. K. Amann Transplantationsregisters mit einem Dialyseregister. Prof. Dr. M. D. Alscher Prof. Dr. A. Kribben Aus folgenden Gründen halten wir eine solche Datenverknüpfung für Dr. T. Weinreich unerlässlich: Kuratorium: • Die Nephrologie ist in der Transplantationslandschaft einzigartig, da es Prof. Dr. A. Kribben flächendeckend und jahre/jahrzehntelang Nierenersatzverfahren gibt, die (Vorsitzender)
    [Show full text]
  • Value of Donor–Specific Anti–HLA Antibody Monitoring And
    CLINICAL RESEARCH www.jasn.org Value of Donor–Specific Anti–HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss † †‡ | Denis Viglietti,* Alexandre Loupy, Dewi Vernerey,§ Carol Bentlejewski, Clément Gosset,¶ † † †‡ Olivier Aubert, Jean-Paul Duong van Huyen,** Xavier Jouven, Christophe Legendre, † | † Denis Glotz,* Adriana Zeevi, and Carmen Lefaucheur* Departments of *Nephrology and Kidney Transplantation and ¶Pathology, Saint Louis Hospital and Departments of ‡Kidney Transplantation and **Pathology, Necker Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; †Paris Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, UMR-S970, Paris, France; §Methodology Unit (EA 3181) CHRU de Besançon, France; and |University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania ABSTRACT The diagnosis system for allograft loss lacks accurate individual risk stratification on the basis of donor– specific anti–HLA antibody (anti-HLA DSA) characterization. We investigated whether systematic moni- toring of DSA with extensive characterization increases performance in predicting kidney allograft loss. This prospective study included 851 kidney recipients transplanted between 2008 and 2010 who were systematically screened for DSA at transplant, 1 and 2 years post-transplant, and the time of post– transplant clinical events. We assessed DSA characteristics and performed systematic allograft biopsies at the time of post–transplant serum evaluation. At transplant, 110 (12.9%) patients had DSAs; post- transplant screening identified 186 (21.9%) DSA-positive patients. Post–transplant DSA monitoring im- proved the prediction of allograft loss when added to a model that included traditional determinants of allograft loss (increase in c statisticfrom0.67;95%confidence interval [95% CI], 0.62 to 0.73 to 0.72; 95% CI, 0.67 to 0.77).
    [Show full text]
  • April 2–6, 2008 Gaylord Texan, Dallas, Texas Spring
    Spring ’08 Clinical Meetings April 2–6, 2008 Gaylord Texan, Dallas, Texas JC A[[fkfm_j^A;;F <_dZekj^emj^[DWj_edWbA_Zd[o<ekdZWj_edÊi A_Zd[o;Whbo;lWbkWj_edFhe]hWcYedj_dk[i je[nfWdZ$$$ @::E^hi]ZaVg\ZhiYZiZXi^dcegd\gVb^ci]Z Jc^iZYHiViZh[dg`^YcZnY^hZVhZ# BdgZi]Vc&%%!%%%eVgi^X^eVcih @::E^h[daadl^c\"jel^i]eVgi^X^eVcihdkZg VcZmiZcYZYeZg^dYd[i^bZ# <adWVaZmeVch^dcd[@::E^hjcYZglVn# B[Whdceh[WXekjA;;F m^_b[oekWh[Wjj^[Yed\[h[dY[$ &# K^hijhVii]ZC@;Wddi],&.[dgi]ZaViZhi^c[dgbVi^dc# '#?d^cjh[dgV[gZZ8B:7gZV`[VhiHnbedh^jb^c<gVeZk^cZ8 dcHVijgYVn!6eg^a*!'%%-[gdb+/%%VbÄ-/%%Vb/ Æ8]gdc^X@^YcZn9^hZVhZ>ciZgkZci^dch/ >begdk^c\8@9VcY8K9DjiXdbZh#Ç (# K^Zli]ZaViZhi@::EYViVWZ^c\egZhZciZY^c&&edhiZgh Yjg^c\i]ZedhiZghZhh^dc#Add`[dgedhiZgcjbWZgh/)*!*(! +)!,*!,,!,-!'%*!',%!'-'!'-(VcY'-.# NdjXVcVahdk^h^ia[[fedb_d[$eh][dgi]ZaViZhi@::E^c[dgbVi^dcVcYVhX]ZYjaZd[ hXgZZc^c\hVXgdhhi]ZJ#H# www.keeponline.org '%%-CVi^dcVa@^YcZn;djcYVi^dc!>cX#6aag^\]ihgZhZgkZY#%'"(*"),(6 Prints: 4C — Live Size: 8"w x 11"h Size:Trim 9"w x 12"h Bleed Size: 9.25"w x 12.25"h Ad PGF-0288 AST Abstracts/American of Journal Transplantaion Mechanical resized from by PGF-0163 CF •C •M •Y •Y •K Your Partner in Transplantation At Astellas, we are committed to uncovering new possibilities in immunology through broad scale research aimed at new product development. Through the transference and sharing of scientifi c knowledge, we work in partnership with healthcare professionals like you to positively impact patient care. Our goal remains clear: Enhance the practice of transplantation.
    [Show full text]
  • MODERN MATHEMATICS 1900 to 1950
    Free ebooks ==> www.Ebook777.com www.Ebook777.com Free ebooks ==> www.Ebook777.com MODERN MATHEMATICS 1900 to 1950 Michael J. Bradley, Ph.D. www.Ebook777.com Free ebooks ==> www.Ebook777.com Modern Mathematics: 1900 to 1950 Copyright © 2006 by Michael J. Bradley, Ph.D. All rights reserved. No part of this book may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage or retrieval systems, without permission in writing from the publisher. For information contact: Chelsea House An imprint of Infobase Publishing 132 West 31st Street New York NY 10001 Library of Congress Cataloging-in-Publication Data Bradley, Michael J. (Michael John), 1956– Modern mathematics : 1900 to 1950 / Michael J. Bradley. p. cm.—(Pioneers in mathematics) Includes bibliographical references and index. ISBN 0-8160-5426-6 (acid-free paper) 1. Mathematicians—Biography. 2. Mathematics—History—20th century. I. Title. QA28.B736 2006 510.92'2—dc22 2005036152 Chelsea House books are available at special discounts when purchased in bulk quantities for businesses, associations, institutions, or sales promotions. Please call our Special Sales Department in New York at (212) 967-8800 or (800) 322-8755. You can find Chelsea House on the World Wide Web at http://www.chelseahouse.com Text design by Mary Susan Ryan-Flynn Cover design by Dorothy Preston Illustrations by Jeremy Eagle Printed in the United States of America MP FOF 10 9 8 7 6 5 4 3 2 1 This book is printed on acid-free paper.
    [Show full text]
  • 2015 UNOS Transplant Mangement Forum Abstracts
    ABSTRACTS 2015 UNOS Transplant Management Forum, San Diego, CA CATEGORY 1 Cost Reduction/Increase in Work Efficiency/Patient Care Safety Programs ABSTRACT C1-A FEASIBILITY OF REMOTE MONITORING OF VITAL SIGNS AMONG KIDNEY TRANSPLANT RECIPIENTS Stephen Pastan, MD, Emory Transplant Center, Atlanta, GA Purpose: We conducted a pilot study of in-home monitoring in a cohort of renal transplant patients to determine the feasibility of remotely monitoring vital data, and to identify abnormal values that could be intervened upon early to avoid hospital readmissions. The use of in-home "hovering" technologies, which can remotely transmit relevant clinical data, has been associated with decreased readmission rates and reduced costs in other patient populations. However, no study has examined the impact of a hovering platform in post-kidney transplant patients – a population at high-risk for readmissions. Methods: A cohort of adult kidney transplant recipients within 12 months of transplant were identified by transplant center coordinators and providers, and were given the hovering platform equipment during a post-transplant clinic visit. Patients were trained on equipment setup and use by study staff and were instructed to measure blood pressure, pulse oxygen, weight, temperature, and blood sugar levels (if diabetic) for 1 to 3 months. Except for the thermometer and glucometer, devices were connected via blue tooth to a main hub. Vital measurements were transmitted to the hub and automatically downloaded by cell or land-line to a software program that was monitored daily by study staff. In the case of an abnormal reading, study staff notified the patient’s nurse and/or physician, who contacted the patient and intervened as necessary.
    [Show full text]
  • Anhang 1 Eurotransplant International Foundation
    Anhang 1 Eurotransplant International Foundation A m 1. Dezember 1997 trat in der Bundesrepublik Deutschland das Gesetz über die Spende, Entnahme und Übertragung von Organen, kurz Transplantationsgesetz (TPG) genannt, in Kraft. Es regelt neben den Voraussetzungen für eine Organspende auch die Verteilung der verfügbaren vermittlungspflichtigen Or- gane (Herz, Lunge, Leber, Niere, Bauchspeicheldrüse, Dünn- darm). Hierzu führt es in § 12(3) aus, dass die vermittlungs- pflichtigen Organe von einer Vermittlungsstelle nach Regeln, die dem Stand der Erkenntnisse der medizinischen Wissen- schaft entsprechen, insbesondere nach Erfolgsaussicht und Dringlichkeit für geeignete Patienten zu vermitteln sind. Die gemeinnützige Stiftung Eurotransplant Foundation (ET) in Lei- den/Niederlande (www.eurotransplant.nl) wurde vom Gesetz- geber mit der Wahrnehmung der Aufgabe der Vermittlungsstel- le beauftragt. Neben der Vermittlungsstelle sieht der Gesetzgeber im TPG auch die Einrichtung einer Koordinierungsstelle – wahrgenom- men von der Deutschen Stiftung für Organtransplantation (DSO) – zur Koordinierung aller Aspekte der Organsspende vor. ET ist eine 1967 von dem Transfusionsmediziner Jon van Rood ins Leben gerufene Non-Profit-Organisation. Van Rood erkannte die grundlegende Bedeutung des HLA-Systems für die allogene Organtransplantation und regte an, das HLA von Spen- der und Empfänger bei Zuteilung von Organtransplantaten, ins- besondere bei der Nierentransplantation, zu berücksichtigen. Um über einen größeren Pool an Spendern und Empfängern zu verfügen und somit eine optimierte Organzuteilung zu errei- 172 z Anhang 1 Eurotransplant International Foundation chen, wurde ein erster europäischer Transplantationsverbund von den Ländern Belgien, Niederlande, Luxemburg und Deutschland gegründet. Dieser wurde 1971 durch Österreich und im Jahr 2000 durch den Beitritt von Slowenien erweitert. ET ist eine gemeinnützige Stiftung, die von den beteiligten Staaten bzw.
    [Show full text]
  • American Osler Society
    49th Annual Meeting of the American Osler Society Sir William Osler, quoting Leigh Hunt, “Abou Ben Adhem” Sunday, May 12th – Wednesday May 15th, 2019 Hotel Omni Mont-Royal Montréal, Canada Hotel Omni Mont-Royal 49th Annual Meeting of the AMERICAN OSLER SOCIETY Sunday, May 12th – Wednesday, May 15th, 2019 Hotel Omni Mont-Royal Montréal, Canada Credit: Karen Koshof The Osler Niche contains the ashes of Sir William Osler and Lady Osler, as well as those of Osler’s dear cousin and first Librarian of the Osler Library, W.W. Francis. The Niche was designed with Osler’s wishes in mind. Its realization was not far off the vision imagined by Osler’s alter ego Egerton Yorrick Davis in “Burrowings of a Bookworm”: I like to think of my few books in an alcove of a fire-proof library in some institution that I love; at the end of the alcove an open fire-place and a few easy chairs, and on the mantelpiece an urn with my ashes and my bust or portrait through which my astral self, like the Bishop at St. Praxed’s, could peek at the books I have loved, and enjoy the delight with which kindred souls still in the flesh would handle them. Course Objectives Upon conclusion of this program, participants should be able to: Describe new research findings in the history of medicine. Outline the evolution of medicine in a particular disease. List professional contributions made by others in medicine. Intended Audience The target audience includes physicians and others interested in Osler, medical history and any of the medically oriented humanities who research and write on a range of issues.
    [Show full text]